Iambic Therapeutics Secures $100M in Series B Financing to Propel AI-Driven Drug Discovery and Clinical Advancements.
Iambic Therapeutics, established post-2021 Series A financing, focuses on leveraging AI to expedite the delivery of therapeutics across various target classes and mechanisms of action.